XML 19 R4.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Revenue      
Net product sales $ 210,078 $ 143,526 $ 89,571
Royalty revenue 4,686 3,038 633
Licensing revenue 239 901 2,474
Total revenue 215,003 147,465 92,678
Costs and expenses      
Cost of product sales 11,986 8,423 5,758
Research and development 42,791 29,135 19,586
Selling, general and administrative 106,010 89,063 72,612
Total costs and expenses 160,787 126,621 97,956
Operating income (loss) 54,216 20,844 (5,278)
Other income (expense)      
Interest income 1,482 643 348
Interest expense (543) (1,229) (4,963)
Interest expense-nonrecourse liability related to sale of future royalties (4,548) (3,541) (658)
Changes in fair value of derivative liabilities 448 193 2,809
Loss on extinguishment of debt (671) (2,338) (2,592)
Other (loss) income (15) 38 39
Total other expense (3,847) (6,234) (5,017)
Earnings (loss) before income taxes 50,369 14,610 (10,295)
Income tax (benefit) expense (40,852) 666 630
Net income (loss) $ 91,221 $ 13,944 $ (10,925)
Basic (in dollars per share) $ 1.84 $ 0.29 $ (0.26)
Diluted (in dollars per share) $ 1.76 $ 0.28 $ (0.26)
Weighted-average number of common shares outstanding:      
Basic (in shares) 49,472,434 47,485,258 42,260,896
Diluted (in shares) 51,708,983 51,160,380 42,260,896